The effect and mechanistic study of encequidar on reversing the resistance of SW620/AD300 cells to doxorubicin is a research paper published in Biochemical Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: SW620
National Institutes of Health
Grant: SW620/AD300
National Natural Science Foundation of China
Grant: 82003588
National Cancer Institute
MeSH Terms
Keywords